Volume 22 Issue 7
Jul.  2024
Turn off MathJax
Article Contents
HONG Jiahui, LIU Yongyang, FANG Yukun, QIU Yiyin, FANG Kai, CHEN Qingyong. CRP/ALB combined with lung consolidation in predicting the severity of COVID-19[J]. Chinese Journal of General Practice, 2024, 22(7): 1116-1120. doi: 10.16766/j.cnki.issn.1674-4152.003579
Citation: HONG Jiahui, LIU Yongyang, FANG Yukun, QIU Yiyin, FANG Kai, CHEN Qingyong. CRP/ALB combined with lung consolidation in predicting the severity of COVID-19[J]. Chinese Journal of General Practice, 2024, 22(7): 1116-1120. doi: 10.16766/j.cnki.issn.1674-4152.003579

CRP/ALB combined with lung consolidation in predicting the severity of COVID-19

doi: 10.16766/j.cnki.issn.1674-4152.003579
Funds:

 2020KY1025

  • Received Date: 2023-08-30
    Available Online: 2024-09-05
  •   Objective  Corona Virus Disease 2019 (COVID-19) has become a global pandemic disease, which can lead to multiple organ damage syndrome and high mortality. Therefore, there is an urgent need for reliable biomarkers that can be used for early screening for possible progression to severe infection, which is important for improving clinical prognosis.  Methods  For this retrospective study, basic information and clinical data from December 8, 2022 to January 31, 2023 were extracted from the medical records of patients with COVID-19 admitted to the 903rd Hospital of the People's Liberation Army. On the basis of a new type of coronavirus infection diagnosis and treatment plan 10 (trial version) of parting, after into and exclusion criteria, the patients were divided into two groups, non-severe group (n=57) and severe group (n=37). Univariate analysis was used to screen out statistically significant indicators between the two groups, then multivariate analysis logistic regression was used to screen out independent risk factors affecting the severity of early COVID-19. The receiver operating characteristic curve was used to evaluate and analyze the predictive value of the corresponding indicators for the severity stratification of COVID-19 in the early stage. Finally, a nomogram was used to evaluate the test efficacy of the prediction model.  Results  The C-reactive protein/albumin ratio (CRP/ALB), lung consolidation and coronary heart disease were predictors of severity prediction, the area under the ROC of CRP/ALB was 0.762 (95% CI: 0.663-0.862, P < 0.001), the area under the ROC of lung consolidation was 0.682 (95% CI: 0.573-0.791, P=0.003), and the area under the ROC of coronary heart disease was 0.638(95% CI: 0.520-0.756, P=0.024). The AUC of CRP/ALB and lung consolidation was 0.801(95% CI: 0.708-0.894). The nomogram prediction model and its calibration curve showed that the prediction model had high accuracy with the actual situation.  Conclusion  CRP/ALB combined with lung consolidation can predict the severity of COVID-19.

     

  • loading
  • [1]
    QIN P, DU E Z, LUO W T, et al. Characteristics of the life cycle of Porcine Deltacoronavirus (PDCoV) in vitro: replication kinetics, cellular ultrastructure and virion morphology, and evidence of inducing autophagy[J]. Viruses, 2019, 11(5): 455. DOI: 10.3390/v11050455.
    [2]
    WANG J, ZHU K, XUE Y, et al. Research progress in the treatment of complications and sequelae of COVID-19[J]. Front Med, 2021, 8: 757605. DOI: 10.3389/fmed.2021.757605.
    [3]
    MACHHI J, HERSKOVITZ J, SENAN A M, et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections[J]. J Neuroimmune Pharmacol, 2020, 15(3): 359-386. doi: 10.1007/s11481-020-09944-5
    [4]
    ALPDAGTAS S, ILHAN E, UYSAL E, et al. Evaluation of current diagnostic methods for COVID-19[J]. APL Bioeng, 2020, 4(4): 041506. DOI: 10.1063/5.0021554.
    [5]
    KERMALI M, KHALSA R K, PILLAI K, et al. The role of biomarkers in diagnosis of COVID-19: a systematic review[J]. Life Sci, 2020, 254: 117788. DOI: 10.1016/j.lfs.2020.117788.
    [6]
    SCHNEIDER M. The role of biomarkers in hospitalized COVID-19 patients with systemic manifestations[J]. Biomark Insights, 2022, 17: 11772719221108909. DOI: 10.1177/11772719221108909.
    [7]
    中华人民共和国国家卫生健康委员会. 新型冠状病毒感染诊疗方案(试行第十版)[J]. 中华临床感染病杂志, 2023, 16(1): 1-9. https://www.cnki.com.cn/Article/CJFDTOTAL-JZYL202304001.htm

    NATIONAL Health Commission of the PRC. Diagnosis and treatment plan for COVID-19 (trial version 10)[J]. Chinese Journal of Clinical Infectious Diseases, 2023, 16(1): 1-9. https://www.cnki.com.cn/Article/CJFDTOTAL-JZYL202304001.htm
    [8]
    SILVA D L, LIMA C M, MAGALHÀES V C R, et al. Fungal and bacterial coinfections increase mortality of severely ill COVID-19 patients[J]. J Hosp Infect, 2021, 113: 145-154. doi: 10.1016/j.jhin.2021.04.001
    [9]
    BATTAGLINI D, LOPES-PACHECO M, CASTRO-FARIA-NETO H C, et al. Laboratory biomarkers for diagnosis and prognosis in COVID-19[J]. Front Immunol, 2022, 13: 857573. DOI: 10.3389/fimmu.2022.857573.
    [10]
    MOLINS B, FIGUERAS-ROCA M, VALERO O, et al. C-reactive protein isoforms as prognostic markers of COVID-19 severity[J]. Front Immunol, 2023, 13: 1105343. DOI: 10.3389/fimmu.2022.1105343.
    [11]
    LI J Y, LI M, ZHENG S S, et al. Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19[J]. Biomark Med, 2020, 14(10): 827-837. doi: 10.2217/bmm-2020-0254
    [12]
    师明明, 王雅杰. 血清PCT、ALB及D-D水平与新型冠状病毒肺炎患者病情严重程度间的相关性分析[J]. 标记免疫分析与临床, 2023, 30(6): 918-922. https://www.cnki.com.cn/Article/CJFDTOTAL-BJMY202306004.htm

    SHI M M, WANG Y J. A correlation analysis between serum PCT, ALB and D-D levels and disease severity in patients with novel coronavirus pneumonia[J]. Labeled Immunoassays and Clinical Medicine, 2023, 30(6): 918-922. https://www.cnki.com.cn/Article/CJFDTOTAL-BJMY202306004.htm
    [13]
    马旭灿, 丁颖威, 章炳文. 丙种球蛋白冲击治疗重症社区获得性肺炎的疗效及对患者血清免疫蛋白和淋巴细胞亚群的影响[J]. 中华全科医学, 2021, 19(9): 1497-1499, 1583. doi: 10.16766/j.cnki.issn.1674-4152.002095

    MA X C, DING Y W, ZHANG B W. Effect of gamma globulin pulse therapy on patients with severe community-acquired pneumonia and on serum immune proteins and lymphocyte subsets[J]. Chinese Journal of General Practice, 2021, 19(9): 1497-1499, 1583. doi: 10.16766/j.cnki.issn.1674-4152.002095
    [14]
    KARAKOYUN I, COLAK A, TURKEN M, et al. Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients[J]. Int Immunopharmacol, 2021, 91: 107285. DOI: 10.1016/j.intimp.2020.107285.
    [15]
    JOVIČIĆ B P, RAKOVIĆ I, GAVRILOVIĆ J, et al. Vitamin D, albumin, and D-dimer as significant prognostic markers in early hospitalization in patients with COVID-19[J]. J Clin Med, 2023, 12(8): 2825. DOI: 10.3390/jcm12082825.
    [16]
    ZHANG C, ZHENG F X, WU X Y. Predictive value of C-reactive protein-to-albumin ratio for risk of 28-day mortality in patients with severe pneumonia[J]. J Lab Med, 2023, 47(3): 115-120. doi: 10.1515/labmed-2022-0114
    [17]
    MALÉCOT N, CHRUSCIEL J, SANCHEZ S, et al. Chest CT characteristics are strongly predictive of mortality in patients with COVID-19 pneumonia: a multicentric cohort study[J]. Acad Radiol, 2022, 29(6): 851-860. doi: 10.1016/j.acra.2022.01.010
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(6)

    Article Metrics

    Article views (59) PDF downloads(6) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return